We found under conditions in which intracellular concentrations of TFV-DP are the same in blood and endometrial CD4+ T cells, that MPA but not LNG, NET or progesterone, both suppresses the protective effect of TFV on HIV infection and lowers intracellular concentrations of TDV-DP in blood CD4+ T cells. This evidence concerns the gene CD4 and HIV infectious disease.